Skip to Main Content

Paper Details

Cancer Risks Associated With <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variants.
J Clin Oncol
78
2022
Cancer, PVs, Pathogenic Variants, cancer, cancers, colorectal and gallbladder cancers, female breast and ovarian cancers, male breast cancer, male breast, pancreatic, stomach, and prostate, men, pancreatic cancer, prostate cancer, stomach (, stomach cancer, women
Author NameAffiliation
Timothy R RebbeckHarvard T.H. Chan School of Public Health
Timothy R RebbeckDana-Farber Cancer Institute
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Louise IzattClinical Genetics Department, Guy's and St Thomas' NHS Foundation Trust
Esther M JohnStanford University School of Medicine
Esther M JohnStanford University School of Medicine
Beth Y KarlanDavid Geffen School of Medicine, University of California at Los Angeles
Jeong-Won LeeUlsan University College of Medicine and Asan Medical Center
Susan J RamusUniversity of NSW Sydney
Susan J RamusLowy Cancer Research Center, University of NSW Sydney
Susan J RamusUniversity of NSW Sydney
Susan J RamusLowy Cancer Research Center, University of NSW Sydney
Mary Beth TerryMailman School of Public Health, Columbia University
Amanda B SpurdleQIMR Berghofer Medical Research Institute
Amanda B SpurdleQIMR Berghofer Medical Research Institute
Douglas F EastonCenter for Cancer Genetic Epidemiology, University of Cambridge
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
  • 1 - 21

Datasets

Release 1.2